Sequential first pass radionuclide angiocardiography can be performed in rapid succession using gold-195m because of its low radiation dose and short half-life (30.5 seconds). In 25 patients with known or suspected coronary artery disease, first pass studies with gold-195m were obtained using a computerized multicrystal gamma camera at rest (n = 29), at the end of each 3 minute stage of exercise (n =25) and immediately after exercise (n = 23). In 13 patients, assessment of left ventricular function during exercise with gold-195m was combined with thaIlium-201 stress scintigraphy.
Sequential first pass radionuclide angiocardiography can be performed in rapid succession using gold-195m because of its low radiation dose and short half-life (30.5 seconds). In 25 patients with known or suspected coronary artery disease, first pass studies with gold-195m were obtained using a computerized multicrystal gamma camera at rest (n = 29), at the end of each 3 minute stage of exercise (n =25) and immediately after exercise (n = 23). In 13 patients, assessment of left ventricular function during exercise with gold-195m was combined with thaIlium-201 stress scintigraphy.
Left ventricular ejection fraction at rest assessed with technetium-99mand gold-195m correlated well(r =0.93).
In addition, repeat left ventricular ejection fractions at rest with gold-195m correlated closely (r =0.96). Comparing peak exercise left ventricular ejection fraction Technetium-99m is currently the radionuclide of choice for first pass radionuclide angiocardiography. However, its relative long half-life (6 hours) and patient dosimetry considerations pose some practical limitations to this clinical use of the radiotracer. For example, using technetium-99m labeled pharmaceuticals that are cleared primarily by the kidneys or the reticuloendothelial system, the total number of studies that can be performed in sequence and the dose per study are limited (three studies and 10 mCi, respectively). In addition, the minimal time interval between sequential studies using these radiopharmaceuticals is longer than desirable (especially during exercise) and should be at least with ejection fraction at rest, abnormal left ventricular reserve was found in 20 of 25 patients. Various abnormal patterns of left ventricular ejection fraction response were noted, showing the diagnostic potential of serial exercise angiocardiography. ThaIlium-201 myocardial images, obtained on a single crystal gamma camera after multiple gold-195m injections, were all of good diagnostic quality and were abnormal in 10 of 13 patients. Thus, multiple high count rate first pass studies can be obtained with gold-195m during and after exercise, allowing serial study of physiologic changes in left ventricular function during exercise. ThaIlium-201 myocardial imaging can be performed using the same exercise test, providing direct comparison of myocardial function and perfusion.
10 minutes. Recently, we demonstrated (I) the feasibility of performing rapid sequential first pass radio nuclide angiocardiography in experimental animals using a new shortlived (30.5 seconds) radiotracer, gold-195m. This radionuclide is the daughter of the long-lived parent mercury195m and can be obtained from a shielded tabletop generator. The high yield of gold-195m allows performance of excellent quality high countrate first pass studies.
The present study reports our initial results with this radionuclide in patients with coronary artery disease evaluated during exercise. Use of this short-lived radiotracer allows for rapid sequential assessment of left ventricular ejection fraction by first pass radionuclide angiocardiography at rest and during each stage of exercise. This provides an important means of gaining insight into the physiologic changes in exercise cardiac performance in individual patients. Because of the short half-life of gold-195m, exercise thallium-201 myocardial perfusion imaging can be performed using the same exercise test employed in the assessment of left ventricular function. The present study dem-onstrates the feasibility of combined serial function and perfusion studies.
Methods
Study patients. Twenty-nine patients with an age range of 41 to 71 years were included in this study. Twenty-five of the 29 patients had coronary artery disease documented by one or more of the following: coronary angiography within 6 months of the study (n = 9) , transmural myocardial infarction (n = 15) or typical angina pectoris with ischemic exercise treadmill response (n = 8). Four patients had an atypical chest pain syndrome. All 29 patients were in functional class II or III according to criteria of the New York Heart Association. The patient s were selected on the basis of their willingness to participate in the research protocol and their availability at the time of generator shipment (see later). Informed written consent was obtained from all patients.
Mercury-195m/gold-195m generator. Eight prototype table top mercury-195m/gold-195m generators were used for this study, supplied on a limited basis by Byk-Mallinckrodt (petten , Holland) . The generator has been described previously (1). In brief, it consists of a lead housing containing a glass column on which the parent mercury-195m (half-life of 41.6 hours) is absorbed on inorganic material. The column is flushed with aqueous sodium-thiosulfate/sodium nitrate eluent (supplied by Byk-Mallinckrodt) .
Careful quality control and analysis of performance of each individual generator were performed before it was used with patients . First , the generator was flushed with at least 40 ml of eluent to wash off the mercury-195m and mercury-195 freed from the column by radioautolysis. Subsequently, the eluate (2 ml) was measured in a standard dose calibrator (model CRC-17, Capintec) to determine the amount of gold195m obtained and the breakthrough of mercury-195m . As previously described , absolute calibration was performed using a standard reference source of selenium-75 . Dose calibrator readings for mercury-195m and gold-195m were corrected on the basis of these absolute calibrations. Before the beginning of a patient study , the activity of gold-195m in the eluate was measured 15 seconds after the start of elution, because this represents the approximate time at which the radioactive bolus will be injected. The amount of mercury-195m breakthrough in the eluate was measured 15 minutes after elution.
We calculated estimated human radiation doses based on biodistribution studies of mercury-195m and its descendants , gold-195m, mercury-195 and gold-195 in animals at 48 hours after injection (1). The target organs for mercury 195m and its descendants are the kidneys , which receive 0 .017 rad//LCi of mercury-195m. To limit the radiation dose to the kidneys to 5 rads (as recommended by U.S. Food and Drug Administration guidelines) (2), the maximal amount of mercury-195m that can be injected in an individual patient per study should not exceed 295 /LCi . Thus , by knowing the amount of mercury-195m breakthrough in the eluate , the maximal number of injections that can be administered to an individual patient can be calculated for each individual generator.
After initial animal studies (1) , the sterile and pyrogenfree prototype generators were approved for use in patients by the Yale-New Haven Hospital Radioisotope and Radioactive Drug Research Committees; the protocol also was approved by the Institutional Human InvestigationCommittee.
Exercise protocol. Before the exercise study, the patients were familiarized with the exercise imaging laboratory and the experimental protocol. The electrocardiogram was monitored during exercise using a 4 lead system (HewlettPackard, 1500A). Heart rate, sphygmomanometric blood pressure and electrocardiograms were obtained at rest before exercise and once every minute during exercise. Exercise was performed on an upright bicycle ergometer (Quinton Instruments, model 884), with the patient sitting in front of the detector , which was rotated from the usual orientation. The patient pedalled at a constant speed beginning with a load of 150 kpm/min. Every 3 minutes , the load was increased by 150 kpm/min. The end points of exercise were defined as follows: onset of typical angina , 2 mm or greater horizontal ST segment depression in an electrocardiographic lead that was normal at rest , life-threatening arrhythmias , hypotension , severe fatigue or attainment of target heart rate. After exercise , heart rate, blood pressure and the electrocardiogram were monitored at 3 minute interval s until these variables had returned to pretest levels .
First pass radionuclide angiocardiography. First pass radionuclide angiocardiography was performed with a computerized multicrystal scintillation camera (Baird-Atomic System-77). The method for first pass radionuclide angiocardiography employed in our laboratory previously has been standardized and validated using technetium-99m (3). All patients had an 18 gauge, 1 inch (2.54 ern) polyethylene catheter placed in a large antecubital vein for radionuclide injection (described later). Subsequentl y, the lead-shielded mercury-195m/gold-195m generator was placed approximately 30 cm from the injection site and adjacent to the crystal surface of the gamma camera to minimize scatter emanating from the generator. At least 15 minutes were allowed to pass between catheter placement and the first radionuclide injection to minimize the effect of increased sympathetic tone associated with venipuncture and prestudy anxiety.
Validation studies at rest. The first 18 patients had a rest study with 15 mCi of technetium-99m-diethylenetriaminepentaacetic acid (DTPA) using previously described techniques (3) . After a period of approximately 20 minutes , the gold-195m generator was eluted five times to wash off the excess of mercury-195m , mercury-195 and gold-195 . Subsequently , two rest studies separated by 2 to 3 minute intervals were performed using gold-195m in 29 patients. In five patients, multiple rest studies (three in four patients, six in one patient) using gold-195m were performed at I minute intervals. These rest studies were performed with the patient sitting in an upright position on the bicycle ergometer. The patient was oriented in the anterior position with the detector of the multicrystal camera vertical and directly in front of the chest. The feet were placed on the bicycle pedals in a position identical to that employed during the subsequent exercise study.
For the first pass studies using gold-195m, the patients catheter in the antecubital vein was connected to the outlet of the column by a 3 ml extension tube filled with normal saline solution. The generator was flushed rapidly with 2 ml of eluent introducing the eluate directly into the catheter. First pass radionuclide angiocardiography was performed in the anterior position by flushing the dose as rapidly as possible with 20 cc of normal saline solution contained in a separate syringe attached to the extension tube by a threeway stopcock. This technique is identical to the one employed routinely in our laboratory for technetium-99m. The time interval between elution of the generator and rapid injection was approximately 7 to 10 seconds.
Exercise studies. Twenty-five patients had gold-195m first pass angiocardiography during multiple stages of exercise. During exercise, first pass angiocardiography was repeated during the last 15 seconds of each 3 minute exercise stage. Within less than I minute of the termination of exercise, an additional first pass study was performed. This latter study was obtained with the patient pedaling slowly against no resistance.
Combined stress thallium-201 myocardial perfusion imaging and gold.195m left ventricular function study.
The potential effect of gold-195m injections (or mercury195m breakthrough) on thallium-20 I imaging was assessed as follows. Two patients received a single injection of eluate containing a known amount of mercury-195m. Five minutes later, a 5 minute Image of the cardiac region in the left anterior oblique position was obtained using a single crystal gamma camera equipped with an all purpose parallel-hole collimator. The energy window was set over 80 keY. From the collected counts, the count rate/min per /-LCi of mercury195m was determined.
In 13 patients, the efficiency of performing combined myocardial perfusion and left ventricular function studies from a single exercise test was evaluated employing thallium-20 I and gold-195m. Two mCi of thallium-20 I was injected in the intravenous line when it appeared that the patient was approaching the end point of exercise. The patient was then encouraged to continue exercising for at least I minute more. After completion of the gold-195m first pass studies as described, myocardial imaging was begun within less than 5 minutes of the end of exercise. Imaging was performed using a single crystal gamma camera (General Electric 400T), equipped with an all purpose parallel-hole collimator interfaced with a dedicated microcomputer (STAR, General Electric). The energy window (20%) was set over 80 keY. Images were obtained for a preset time (10 minutes) in the anterior, left anterior oblique and left lateral positions. Delayed imaging was performed for identical time per view as for the immediate postexercise study 3 to 4 hours after the initial study. Background-subtracted images were displayed on white and black Polaroid film and were analyzed qualitatively by visual inspection.
Processing first pass studies. The scintillation data obtained of the transit of the bolus through the central circulation were recorded at 50 ms/frame for the rest studies and at 25 ms/frame for the exercise studies and stored in computer memory. The pulse height analyzer settings of the multicrystal were adjusted for the photon energy of the radiotracer used. For the 262 keY photons from gold-195m, the settings were window 50, bias 8 and lower level 20; for the 140 keY photons from technetium-99m, the settings were window 30, bias 6 and lower level 10. Field uniformity correction for studies with gold-195m was performed using a flood source containing mercury-203 (279 keY). A cobalt-57 flood source (123 keY) was employed for studies with technetium-99m. The data were corrected for the decay of radionuclide for processing of the first pass studies using gold-195m. Subsequent processing was performed as described previously (3) . A background-corrected time-activity curve (summed representative cycle) was generated from an area of interest over the left ventricle. Left ventricular ejection fraction was then calculated in the usual manner: end-diastolic counts -end-systolic counts -i-end-diastolic counts.
The lower limit of normal for left ventricular ejection fraction at rest in our laboratory is 55% (4). On the basis of results of previous reproducibility and variability studies in our laboratory, an absolute change of ejection fraction between two studies greater than 5% is considered to be a significant and nonrandom change (5) . In patients with left ventricular ejection fraction at rest less than 75%, the normal left ventricular response to exercise, on the basis of one at rest and one peak exercise value, is defined as an absolute increase of greater than 5% in left ventricular ejection fraction. Regional wall motion was analyzed qualitatively by superimposition of the end-diastolic perimeter on the endsystolic image of the left ventricle (5).
Statistical methods. Data are expressed as the mean ± standard deviation. Comparison of radionuclide data at rest was made by a paired t test. Regression equations and correlation coefficients were derived by standard formulas.
Results
Mercury-195m/gold-195m generator. The eight generators used for the present study contained 169 ± 26 mCi of mercury-195m on the day of use. The activity of gold- 195m obtained at 15 seconds after elution of these five generators ranged from 37 to 16 mCi (mean 23 ± 8). The yield of gold-195m at the time of elution was 39 ± 6% (expressed as percent of gold-195m activity on the generator). The mercury-195m breakthrough/2 ml of eluate ranged from 5 to 50 /-LCi (mean 32 ± 12). Therefore, in order not to exceed a dose of 5 rads to the kidney, or a total of 295 /-LCi of mercury-195m (see previously), the total number of sequential injections permitted per patient ranged from 6 to 59 (mean 10 ± 4).
Gold-195m first pass studies. All first pass studies obtained with gold-195m were of excellent technical quality, indistinguishable from those with technetium-99m (Fig. I) . There was good temporal separation of the right and left heart phases of the first transit of the radioactive bolus through the central circulation. Visually, the images with gold-195m were comparable with those obtained with technetium-99m. For a total of 166 gold-195m studies at rest and exercise, the mean count rate acquired in the whole field of view, uncorrected for decay during the left ventricular phase of the bolus, was 211,128 ± 13,27l!second. The mean count rate in the end-diastolic region of interest over the left ventricle, decay-and background-corrected was 9,326 ± 1,056 counts. These count rates are equal to or slightly greater than those obtained with 15 mCi of technetium-99m: 182,462 ± 12,260 counts/second in the whole field of view during the left ventricular phase and 4,260 ± 728 counts in the end-diastolic region of interest over the left ventricle. The background build-up during sequential first pass studies using gold-195m was minimal, ranging from 3 to 12% in the end-diastolic left ventricular region of interest. The background activity is mainly from mercury-195m accumulation in liver and kidneys.
Rest technetium-99m and gold-195m studies. Left ventricular ejection fractions at rest assessed with technetium-99m-DTPA and gold-195m correlated well (r = 0.93) in the 18 patients who had both studies. The absolute mean interstudy difference was 4 ± 4%. Mean left ventricular ejection fraction with technetium-99m was 47 ± 14% and with gold-195m, 47 ± 14%.
Repeat left ventricular ejection fraction at rest determined by consecutive gold-195m studies also corresponded closely (r = 0.96) in 29 patients. The absolute mean interstudy difference was 4 ± 2%. Mean left ventricular ejection fraction was 50 ± 14 and 50 ± 14%, respectively. In the five patients who had multiple determinations of left ventricular ejection fraction at rest with gold-195m at I minute intervals, the mean absolute interstudy difference between consecutive studies was 3 ± 0.7%.
Exercise gold-195m studies. The mean exercise duration was 9.6 ± 2 minutes. Twenty-one patients exercised to symptom-limited fatigue. Four patients discontinued exercise because of angina. Eight patients (including three with angina) had an ischemic electrocardiographic response (:2: I mm horizontal ST segment depression in a lead that was normal at rest). Comparing mean rest ejection fraction with peak exercise, abnormal exercise left ventricular reserve was demonstrated in 20 of 25 patients. In this small number of patients, various abnormal patterns (Fig. 2 , Table I) left ventricular ejection fraction immediately after exercise was significantly greater (> 5%) than at rest. Mean left ventricular ejection fraction immediately after exercise was 57 ± 14% compared with 50 ± 12% at rest (p < 0,01). Figure I shows images of a representative example of exercise studies using serial gold-195m injections. Thallium-2Ot imaging. The multiple gold-195m first pass studies before myocardial imaging did not affect the diagnostic quality of analog thallium-201 images. Nevertheless, there was measureable background activity after the administration of eluate in the 80 keV thallium window, originating from mercury-195m breakthrough accumulated in the kidneys and liver. We measured 380 counts/min in the whole field of view per p.C1 of mercury-195m injected. This background activity is approximately stable over a 3 to 4 hour period, Figure 3 shows excellent quality thallium-201 images obtained in a patient who received seven injections of gold-195m. Figure 4 compares a thallium-20 I image. after a total of 12 injections and a total of 250 p.Ci of mercury-195m administered. to that obtained in the same patient after a routine thallium-20 I stress test.
The thallium-20 I images were of good diagnostic quality in all 13 patients. In three patients with atypical chest pain, the images were entirely normal, both immediately after exercise and at delayed imaging. The regional wall motion on the exercise ventriculograms in these patients was also normal. The remaining 10 patients had abnormal thallium images showing evidence of either myocardial infarction or exercise-induced myocardial ischemia or both. In all 10 patients. regional left ventricular wall motion was abnormal during exercise at the anatomic location of the thallium-20 I perfusion defect.
Discussion
This study demonstratesthe feasibility of performing rapid. sequential determination of left ventricular ejection fraction using gold-195m in patients and is a continuation of our previous work with this radionuclide in animals (I) , This new radionuclide allows monitoring of rapid changes in left ventricular function using the first pass technique during interventions such as upright exercise ,
Comparison of gold-195m and technetium-99m first pass studies. The patient first pass studies obtained with gold-195m were of high technical quality and indistinguishable from studies usually obtained with technetium-99m in Figure 2 our laboratory. Using the multicrystal gamma camera, count rates with gold-195m were excellent and, therefore, statistically reliable calculation of left ventricular ejection fraction was obtained. The correlation between left ventricular ejection fractions assessed with technetium-99m and gold-195m was excellent, as was the correlation between repeat gold195mstudies. Similar accuracy and reproducibility of gold195m first pass studies have been reported by Mena et al. (6) .
The short half-life of gold-195m and the minimal amount of long-lived mercury-1 95m in the eluate resulted in low background activity and allowed rapid sequential determinations of left ventricular ejection fraction. In the present study, individual determinations of left ventricular ejection fraction during exercise were separated by 3 minutes because data were obtained at the end of each stage of the exercise protocol. However. as shown in our study, shorter time intervals are possible. The multiple repeat studies at rest and the studies immediately after exercise were performed at I minute intervals and resulted in good quality studies.
Patient radiation exposure. It is of clinical relevance that, even when left ventricular performance is determined during each stage of exercise, the total radiation dose to the patient is significantly lower than that with a single dose of the conventional radiotracer technetium-99m. For example, compared with 20 mCi of technetium-99m, 20 mCi of gold195m exposes the kidneys to 5 times less radiation, and the whole body to 20 times less (1) . The dosimetry using gold195m is determined by the breakthrough of the long-lived parent, mercury-195m. It is essential that each generator be analyzed for the breakthrough of mercury-195m, because this determines the maximal number of injections that can be given in an individual patient. This is a relatively simple process that can be performed with routine equipment available in a nuclear medicine radiopharmacy ( J). In addition, the long-lived decay product of gold-195m, gold-195 (halflife = 183 days) can be kept at a minimal level by short elution intervals « 5 minutes).
First pass and multigated equilibrium angiocardiography during exercise. For exercise studies, the first pass technique offers distinct technical advantages over multigated equilibriumcardiac blood pool imaging. The first pass data are acquired over a short period of time and left ventricular ejection fraction is derived from 3 to 5 cardiac cycles. Therefore, first pass left ventricular ejection fraction reflects more accurately left ventricular function at a distinct point in time during exercise than multigated equilibrium ejection fraction, which is acquired over several hundreds of heart beats and represents an "average " value. Because of the limited count rate capability of conventional single crystal gamma cameras, the multigated equilibrium technique is preferred during exercise, and many investigators (7) (8) (9) (10) (11) have shown the clinical usefulness of this approach. Serial left ventricular ejection fractions during exercise, as performed in the present study with gold-195m, also can be obtained with technetium-99m using 2 minute multigated acquisitions. However, these studies frequently have less than optimal count rate densities in the left ventricular enddiastolic region of interest. In addition, body motion during exercise may have a major degrading effect on the quality of equilibrium blood pool studies, which may be reflected in poor reproducibility of data processing (12) . With the multigated equlibrium technique, it is possible to obtain multipleviewsduringrepeat exercisestudies, allowingmore complete analysis of regional wall motion analysis (13). This is not readily possible employing technetium-99m first pass studies, but could conceivably be performed using gold195m. Serial left ventricular ejection fraction during exercise. Serial assessment of left ventricular ejection fraction during various stages of exercise has been reported previously by Caldwell et al. (8) and others (9-11), using the multigated equilibrium cardiac blood pool technique. These investigators observed a similar variability in response to exercise in patients with coronary artery disease particularly the " overshoot" of the left ventricular ejection fraction immediately after exercise. A similar improvement of left ventricular function, in particular of regional wall motion, was reported recently by Rosanski et al. (13) . Sudden pooling of blood in the capacitance circulation of the legs and a consequent decrease of left ventricular preload immediately after termination of upright exercise has been suggested as a possible mechanism for this phenomenon. By virtue of the heterogeneity of the patients included in the present study, several different exercise responses were observed. This investigation, however, was not designed to assess the diagnostic utility of serial ejection fraction determination during exercise but rather its feasibility . The various patterns observed in this study illustrate the diagnostic potential of this approach.
Combined imaging with gold-195m and thallium-201. The short half-life of gold-195m offers another potentially interesting clinical application. Not only can left ventricular function be monitored at short time intervals during various stages of exercise, but simultaneous analysis of myocardial perfusion using thallium-20l can also be performed. Once the conventional tracer technetium-99m is administered to a patient, thallium-20 I imaging generally cannot be performed for at least 24 hours so that technically acceptable images can be obtained. In the present study, however, thallium-201 injected at peak exercise could be imaged without difficulty after discontinuation of exercise, even after multiple injections of gold-195m (Fig. 3 and 4) . Although gold-195m itself does not effect thallium-20I imaging, the breakthroughof mercury-195m in the eluate may The patient exercised to the same work load and heart rate as during the routine thallium-20I stress test. Although there is increased background activity from accumulated mercury-195m, the thallium image is of diagnostic quality and shows again a stress-induced inferoapical defect (arrow) . LAO = left anterior oblique.
significantly contribute to background activity in the 80 keY thallium window. The cumulative dose of mercury-195m after 10 injections, for example, may vary from 50 to 300 J-LCi, which is a relatively significant source of radioactivity compared with the 2 mCi of thallium-201 administered . In additionto high-energy photons (262 to 560 kev), mercury195m also emits low-energy X-rays at 67 to 80 keY (51%). The background activity from mercury-195m in liver and kidney is relatively stable over the time period of initial and delayed thallium-201 imaging. Therefore, although this extraneoussource of radioactivity should be considered, quantitative analysis of thallium-20 I kinetics should be unaffected. It is of clinical significance that combined imaging with gold-195m and thallium-20 I allows assessment of both the functional response to exerciseand the presenceof exerciseinduced myocardial hypoperfusion, as well as thallium-201 myocardial kinetics, during a single exercise session. Several studies (8, (14) (15) (16) (17) have shown the complementary value of performing exercise myocardial perfusion imaging and left ventricular function studies in patients with coronary artery disease. By obtaining these studies simultaneously, this approach may provide a more reliable assessment of the functional significance of coronary artery stenosis. This combined technique also has obvious advantages in relation to cost effectiveness of patient evaluation, because only one exercise test is needed to obtain this information . Even with the development of new technetium-99m-Iabeled myocardial perfusion imaging agents, this combined approach would be feasible because of the difference in primary photopeak of the radionuclides.
Continuous infusion of gold-195m. Reliable first pass studies require instruments with high count rate capability such as the computerized multicrystal gamma camera used in this study. It is generally agreedthat a conventional single crystal camera is not optimally suited for first pass studies. On the other hand, the multicrystal camera is not ideal for performing thallium-201 myocardial imaging. We previously demonstrated the feasibility of performing equilibrium-gated cardiac bloodpoolstudiesemployingcontinuous infusion of gold-195m (1,18). This technique could be a practical alternative when a single crystal camera is being used for simultaneous assessment of myocardial function and perfusion at rest and during exercise. The short halflife of gold-195m also allows rapid alternation of imaging modes. Discontinuation of continuous infusion of gold-195m allows switching to imagingof a different radioisotope such as thallium-20 I.
Other short-lived radiotracers. Other short-lived radiotracers that have been proposed recently for first pass radionuclide angiocardiography include tantalum-178 (half life = 9.3 minutes) and iridium-199m (half-life = 4.96 seconds). A major limitation of tantalum-I78 for this application is the low energy of the major photon emissions (55 to 65 keY) and high energy background activity (500 keV), which pose problems for appropriate collimation (19) (20) . In contrast, iridium-199m has excellent photon energy (129 keY) for imaging (21) . Treves et al. (22) demonstrated the feasibility to detect and quantitate left to right cardiac shunts in infants using this radiotracer. The relatively short half-life of iridium-199m, which makes it ideally suited for small children. may be a limitation for application in adults with longer central circulation time.
Clinical implications. Gold-195m is a new radionuclide that offers potentially important new clinical applications . With the expected further technical development of gamma cameras permitting acquisition of higher count rates, the first pass technique may well become the method of choice for performing exercise studies. Consideration will need to be given to medium-energy collimation, detector shielding and adequate crystal thickness to maintain both intrinsic resolution and sensitivity. This radionuclide will not only decrease patient radiation dose per study, but will also provide a means of obtaining insight intothe physiologic changes occurring during exercise or interventions in patients with cardiac disease. These physiologic data may have potential value for the management of these patients. In addition , the short half-life of the radionuclide makes it possible to combine various imaging techniques and obtain simultaneous information concerning both myocardial function and perfusion.
